Literature DB >> 15613330

In vitro and in vivo mutational analysis of the 3'-terminal regions of hepatitis e virus genomes and replicons.

Judith Graff1, Hanh Nguyen, Chaiyan Kasorndorkbua, Patrick G Halbur, Marisa St Claire, Robert H Purcell, Suzanne U Emerson.   

Abstract

Hepatitis E virus (HEV) replication is not well understood, mainly because the virus does not infect cultured cells efficiently. However, Huh-7 cells transfected with full-length genomes produce open reading frame 2 protein, indicative of genome replication (6). To investigate the role of 3'-terminal sequences in RNA replication, we constructed chimeric full-length genomes with divergent 3'-terminal sequences of genotypes 2 and 3 replacing that of genotype 1 and transfected them into Huh-7 cells. The production of viral proteins by these full-length chimeras was indistinguishable from that of the wild type, suggesting that replication was not impaired. In order to better quantify HEV replication in cell culture, we constructed an HEV replicon with a reporter (luciferase). Luciferase production was cap dependent and RNA-dependent RNA polymerase dependent and increased following transfection of Huh-7 cells. Replicons harboring the 3'-terminal intergenotypic chimera sequences were also assayed for luciferase production. In spite of the large sequence differences among the 3' termini of the viruses, replication of the chimeric replicons was surprisingly similar to that of the parental replicon. However, a single unique nucleotide change within a predicted stem structure at the 3' terminus substantially reduced the efficiency of replication: RNA replication was partially restored by a covariant mutation. Similar patterns of replication were obtained when full-length genomes were inoculated into rhesus macaques, suggesting that the in vitro system could be used to predict the effect of 3'-terminal mutations in vivo. Incorporation of the 3'-terminal sequences of the swine strain of HEV into the genotype 1 human strain did not enable the human strain to infect swine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15613330      PMCID: PMC538530          DOI: 10.1128/JVI.79.2.1017-1026.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  A novel virus in swine is closely related to the human hepatitis E virus.

Authors:  X J Meng; R H Purcell; P G Halbur; J R Lehman; D M Webb; T S Tsareva; J S Haynes; B J Thacker; S U Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Viral ribonucleoprotein complex formation and nucleolar-cytoplasmic relocalization of nucleolin in poliovirus-infected cells.

Authors:  S Waggoner; P Sarnow
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

3.  The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton.

Authors:  M Zafrullah; M H Ozdener; S K Panda; S Jameel
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein.

Authors:  M Zafrullah; M H Ozdener; R Kumar; S K Panda; S Jameel
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV.

Authors:  X J Meng; P G Halbur; J S Haynes; T S Tsareva; J D Bruna; R L Royer; R H Purcell; S U Emerson
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

6.  Characterization of a prototype strain of hepatitis E virus.

Authors:  S A Tsarev; S U Emerson; G R Reyes; T S Tsareva; L J Legters; I A Malik; M Iqbal; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

7.  Genetic and experimental evidence for cross-species infection by swine hepatitis E virus.

Authors:  X J Meng; P G Halbur; M S Shapiro; S Govindarajan; J D Bruna; I K Mushahwar; R H Purcell; S U Emerson
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

8.  Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV).

Authors:  C C Huang; D Nguyen; J Fernandez; K Y Yun; K E Fry; D W Bradley; A W Tam; G R Reyes
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

9.  Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity.

Authors:  V Lohmann; F Körner; U Herian; R Bartenschlager
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

10.  Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome.

Authors:  A W Tam; M M Smith; M E Guerra; C C Huang; D W Bradley; K E Fry; G R Reyes
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

View more
  30 in total

1.  Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient.

Authors:  Toshinori Tanaka; Masaharu Takahashi; Hideyuki Takahashi; Koji Ichiyama; Yu Hoshino; Shigeo Nagashima; Hitoshi Mizuo; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

2.  Enhancement of interferon induction by ORF3 product of hepatitis E virus.

Authors:  Yuchen Nan; Zexu Ma; Rong Wang; Ying Yu; Harilakshmi Kannan; Brenda Fredericksen; Yan-Jin Zhang
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

3.  Antiviral Candidates for Treating Hepatitis E Virus Infection.

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Subhash G Vasudevan; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 4.  Hepatitis e: molecular virology and pathogenesis.

Authors:  Subrat K Panda; Satya P K Varma
Journal:  J Clin Exp Hepatol       Date:  2013-05-30

5.  The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release.

Authors:  Scott P Kenney; R S Pudupakam; Yao-Wei Huang; F William Pierson; Tanya LeRoith; Xiang-Jin Meng
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

Review 6.  Hepatitis E Virus Genome Structure and Replication Strategy.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

Review 7.  Therapeutic targets for the treatment of hepatitis E virus infection.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Expert Opin Ther Targets       Date:  2015-06-13       Impact factor: 6.902

8.  Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection.

Authors:  Xin Yin; Dong Ying; Sébastien Lhomme; Zimin Tang; Christopher M Walker; Ningshao Xia; Zizheng Zheng; Zongdi Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-18       Impact factor: 11.205

9.  Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding.

Authors:  Tom S Y Guu; Zheng Liu; Qiaozhen Ye; Douglas A Mata; Kunpeng Li; Changcheng Yin; Jingqiang Zhang; Yizhi Jane Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

10.  The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response.

Authors:  Vivek Chandra; Anindita Kar-Roy; Sudha Kumari; Satyajit Mayor; Shahid Jameel
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.